- Filed
- Aug 19, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2024 · Aug 14, 2024 | 1.26M sh |
| Long Term Debt | Q2 2024 · Jun 30, 2024 | $2.01M |
| Cash And Equivalents | Q2 2024 · Jun 30, 2024 | $53.64K |
| Cash And Equivalents | Q2 2024 · Dec 31, 2023 | $11.69K |
| Current Liabilities | Q2 2024 · Jun 30, 2024 | $3.9M |
| Current Liabilities | Q2 2024 · Dec 31, 2023 | $3.61M |
| Total Liabilities | Q2 2024 · Jun 30, 2024 | $3.99M |
| Total Liabilities | Q2 2024 · Dec 31, 2023 | $3.73M |
| Current Assets | Q2 2024 · Jun 30, 2024 | $146.38K |
| Current Assets | Q2 2024 · Dec 31, 2023 | $118.06K |
| Total Assets | Q2 2024 · Jun 30, 2024 | $320.17K |
| Total Assets | Q2 2024 · Dec 31, 2023 | $321.81K |
| Shares Diluted restated | Q2 2024 · Jun 30, 2023 | 1.08M sh |
| Shares Diluted restated | Q2 2024 · Jun 30, 2023 | 1.02M sh |
| Operating Cash Flow | Q2 2024 · Jun 30, 2023 | −$891.27K |
| Stockholders Equity restated | Q2 2024 · Jun 30, 2023 | −$3.04M |
| Stockholders Equity restated | Q2 2024 · Mar 31, 2023 | −$2.35M |
| Stockholders Equity restated | Q2 2024 · Dec 31, 2022 | −$1.9M |
| Eps Diluted restated | Q2 2024 · Jun 30, 2023 | −$0.67 |
| Eps Diluted restated | Q2 2024 · Jun 30, 2023 | −$2.02 |
| Eps Basic restated | Q2 2024 · Jun 30, 2023 | −$0.67 |
| Eps Basic restated | Q2 2024 · Jun 30, 2023 | −$2.02 |
| Sga Expense | Q2 2024 · Jun 30, 2023 | $317.25K |
| Sga Expense | Q2 2024 · Jun 30, 2023 | $652.98K |
| Rd Expense | Q2 2024 · Jun 30, 2023 | $219.16K |
| Rd Expense | Q2 2024 · Jun 30, 2023 | $367K |
| Net Income | Q2 2024 · Jun 30, 2023 | −$723.12K |
| Net Income | Q2 2024 · Jun 30, 2023 | −$2.06M |
| Net Income | Q2 2024 · Mar 31, 2023 | −$1.34M |
| Operating Income | Q2 2024 · Jun 30, 2023 | −$574.01K |
| Operating Income | Q2 2024 · Jun 30, 2023 | −$1.1M |